← FDA DRUG APPROVALS

FDA ANDA · ANDA060188

COR-OTICIN

Sponsor: EPIC PHARMA LLC

APPLICATION
ANDA060188
TYPE
ANDA
ORIGINAL APPROVAL
1968-10-26
LATEST ACTION
1968-10-26
ROUTE
OPHTHALMIC
DOSAGE FORM
SUSPENSION/DROPS
MARKETING STATUS
Discontinued

Products

COR-OTICINDiscontinued
HYDROCORTISONE ACETATE 1.5%, NEOMYCIN SULFATE EQ 3.5MG BASE/ML · SUSPENSION/DROPS · OPHTHALMIC

Approval history

1968-10-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →